GleamWall
中文EN

MCTA Charming Medical Ltd Annual reports only

Services-Misc Health & Allied Services, NEC · SEC CIK 2035992

Financial factors as of 2026-03-31 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-22.7%
TTM net income YoY-101.9%
TTM EPS YoY-100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin99.3%
Operating margin-0.6%
Net margin-0.5%
FCF margin-32.4%
EBITDA margin3.9%

Returns

ROE-0.9%
ROA-0.3%
ROIC (approx.)-34.1%
Asset turnover0.63x

Leverage & solvency

Liabilities / assets47.5%
Debt / equity0.07x
Current ratio1.89x
Interest coverage-1.85x

Cash quality & payout

Operating cash flow / net income53.69x
Accruals ratio15.7%
Payout ratio—
Capex / revenue7.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20262026-03-31FY20252025-03-31
Income statement
Revenue$4.81M$6.22M
Cost of revenue$35,221$15,514
Gross profit$4.77M$6.21M
Operating income-$29,237$1.39M
Interest expense$15,799$20,874
Pretax income$133,466$1.44M
Income tax$156,114$236,082
Net income-$22,648$1.20M
EBITDA$186,837$1.65M
EPS (basic)0.000.08
EPS (diluted)0.000.08
Weighted avg. shares (diluted)16.15M15.34M
Balance sheet
Cash & equivalents$4.70M$816,771
Receivables$201,477$395,901
Inventory$25,623$26,797
Current assets$8.17M$3.37M
PP&E, net$606,901$500,053
Total assets$9.87M$5.36M
Current liabilities$4.33M$4.95M
Short-term debt$185,799$314,226
Long-term debt$185,799—
Total debt$371,598—
Total liabilities$4.69M$5.31M
Shareholders' equity$5.18M$49,243
Net debt-$4.33M—
Cash flow statement
Operating cash flow-$1.22M$425,888
Capital expenditure$339,560$287,527
Free cash flow-$1.56M$138,361
Investing cash flow-$179,015-$2.23M
Financing cash flow$5.29M$521,303
Depreciation & amortization$216,074$263,454

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.